Investment
Features
FeesSafety
Academy
More
Pluang+

Compare 3M Company (MMM) vs Nuwellis Inc (NUWE) Price & Performance

3M CompanyTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

3M Company vs Nuwellis Inc — how do they compare? 3M Company trades at $170.75 (market cap $82.99B), while Nuwellis Inc trades at $2.84 (market cap $1.09M). The key difference: 3M Company is far larger — about 76137.6× Nuwellis Inc's market cap, and 3M Company pays a 1.96% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.

MMMNUWE
Market Cap
$82.99B$1.09M
Sector
IndustrialsTechnology
52-Week High
$174.61$527.46
52-Week Low
$141.10$2.80
Enterprise Value
$91.39B-$722.58K
Dividend Yield
1.96%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

3M Company

No Aura AI signal available yet.

Nuwellis Inc

NUWE trades at $3.00, up 5.26% today, following a 35:1 reverse stock split effective June 26, 2026. The company shows a low P/E of 0.06 and P/S of 0.01, but fundamentals are weak with a -217.22% net income margin and negative ROE. Recent news highlights patent awards and pediatric market expansion, yet cash flow remains negative. Analyst coverage is limited with a split buy/hold consensus.

Outlook is speculative; growth depends on successful commercialization of Aquadex therapy and cost management. Key risks include persistent losses, high cash burn, and competitive pressures. Investors should weigh low valuation against execution risks in the medical technology sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About 3M Company

3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.

Read more on MMM

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE